Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc. - Common Stock (NQ:MASS)

6.940 +0.260 (+3.89%)
Streaming Delayed Price Updated: 10:51 AM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 908 Devices Inc. - Common Stock

< Previous 1 2 3 4 Next >
Metropolitan Washington Council of Governments Adds 908 Devices’ XplorIR to Its Hazardous Materials Response Toolkit
From 908 Devices Inc.
Via Business Wire
Romanian Customs Authority Adopts 908 Devices’ MX908 for Border Security Operations
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
From 908 Devices Inc.
Via Business Wire
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
From 908 Devices Inc.
Via Business Wire
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation
From 908 Devices
Via Business Wire
908 Devices Announces Preliminary First Quarter 2025 Financial Results
From 908 Devices Inc.
Via Business Wire
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
From 908 Devices
Via Business Wire
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
From 908 Devices Inc.
Via Business Wire
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
From 908 Devices Inc.
Via Business Wire
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
From 908 Devices Inc.
Via Business Wire
Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
From 908 Devices Inc.
Via Business Wire
908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
From 908 Devices Inc.
Via Business Wire
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
From 908 Devices Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.